Clinical Trial

Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists

Study acronym: DOLOREPIT
Recruiting
View on ClinicalTrials.gov →
Summary
DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-18; most recent amendment 2025-07-28.
Status change: Not Yet Recruiting → Recruiting 2023-12-19
Trial Details
NCT Number NCT06052384
Lead Sponsor Centre Hospitalier Emile Roux
Conditions Chronic Pain
Enrollment 664 participants
Start Date 2023-12-07
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-07-30